QM

QMS Medical Allied Services Ltd

Q1 FY26Healthcare Equipment & Supplies

QMS Medical Allied Services Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹148
Market cap₹216 Cr
P/E21.4
Updated23 Aug 2026
Read5 min read

The short version

QMS Medical Allied Services aims for strong growth by leveraging its leadership in B2B pharma promotion and patient service programs. - Q-Devices wellness products expected to grow from Rs. QMS Medical Allied Services aims for robust growth with a focus on expanding services, especially in patient service programs and CAMS. - The services segment, including Saarathi, is targeted to grow by 50% year-on-year. - For FY '26, Q-Devices (B2C wellness products) is expected to achieve at least Rs.

From QMS Medical Allied Services Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • QMS Medical Allied Services aims for strong growth by leveraging its leadership in B2B pharma promotion and patient service programs.
  • Q-Devices wellness products expected to grow from Rs. 10 crores in Q1 FY'26 to a conservative target of Rs. 25 crores in FY'26.
  • Services business (including Saarathi acquisition) targets 50% year-on-year growth, expecting to cross Rs. 60 crores revenue combining QMS and Saarathi.
  • The company plans to expand patient service programs and CAMS into new sectors like corporate healthcare and government programs.
  • QMS aims to increase market share in the emerging patient service program space, estimated globally at $70 billion.

2 more points from QMS Medical Allied Services Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what QMS Medical Allied Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The transcript does not explicitly mention any current or future capex or capital investment plans. However, the following points provide some insight related to strategic investments: - QMS Medical Allied Services Limited acquired a controlling 51% stake in Saarathi for Rs. 45 crores, with plans to acquire an additional 49% in two tranches by September 2025 and September 2026 at valuations based on EBITDA multiples. - The company is actively engaged in inorganic growth discussions and strategic acquisitions within the B2B pharma promotion and patient services segment to expand presence.

2 more points from QMS Medical Allied Services Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1Molbio Diagnosti
Rev 2Mar 3
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what QMS Medical Allied Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • There is no specific mention of the current or expected order book or pending orders in the transcript.
  • However, it is noted that QMS's B2C wellness products (Q-Devices) achieved Rs. 10 crores revenue in Q1 FY'26, with a conservative full-year target of Rs. 25 crores, indicating ongoing and expected sales orders.
  • The company is enrolled as a healthcare vendor on the e-Grameen portal, which offers substantial potential to expand product distribution and generate new orders.
  • The patient service programs and CAMS business, including Saarathi acquisition, are growing with a target to grow services revenue by 50% annually.

2 more points from QMS Medical Allied Services Ltd's call on order book

Pro opens every point from 15K+ earnings calls

QMS Medical Allied Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹37 Cr, net profit ₹3 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Laxmi Dental Ltd (Q1 FY26)

    68 crores over two years planned to support expansion. Key concall takeaways from Laxmi Dental Ltd's Q1 FY26 earnings call — and how it ranks against sector…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

QMS Medical Allied Services Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were QMS Medical Allied Services Ltd Q1 FY26 results?

QMS Medical Allied Services aims for strong growth by leveraging its leadership in B2B pharma promotion and patient service programs. - Q-Devices wellness products expected to grow from Rs. QMS Medical Allied Services aims for robust growth with a focus on expanding services, especially in patient service programs and CAMS. - The services segment, including Saarathi, is targeted to grow by 50% year-on-year. - For FY '26, Q-Devices (B2C wellness products) is expected to achieve at least Rs.

What is QMS Medical Allied Services Ltd share price analysis?

QMS Medical Allied Services Ltd currently shows a neutral. The stock trades at a P/E of 21.4 with a market cap of ₹216 Cr. Investors should review the full earnings analysis for detailed insights.

Is QMS Medical Allied Services Ltd planning capital expenditure?

The transcript does not explicitly mention any current or future capex or capital investment plans.

Keep QMS Medical Allied Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.